Economic analysis of use of counterfeit drugs: Health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example

Environmental Health and Preventive Medicine

Volumn 15, Issue 4, 2010, Pages 244-251

  Sugita, Minoru ^a   Miyakawa, Michiko ^b  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOSEI UNIVERSITY   (Japan)

Author keywords

Convenience of acquisition; Counterfeit; Economic analysis; Health impairment risk; PDE5 inhibitor

Indexed keywords

COUNTERFEIT DRUG; ILLICIT DRUG; PHOSPHODIESTERASE V INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; COMA; DRUG COST; DRUG FATALITY; DRUG MARKETING; DRUG SAFETY; DRUG UTILIZATION; ECONOMIC EVALUATION; HEALTH HAZARD; HUMAN; HYPOGLYCEMIA; JAPAN; NEUROLOGIC DISEASE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SINGAPORE;

EID: 77956462440     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-010-0134-5     Document Type: Article

References (26)

1. World Health Organization. How does WHO define a counterfeit drug (medicine)? 2005. http://www.who.int/medicines/services/ counterfeit/faqs/05/en/ .
2. World Health Organization. International Medical Products Anti-Counterfeiting Taskforce (IMPACT). 2006. http://www.who.int/ medicines/services/counterfeit/faqs/count-q-a/en/.
3. World Health Organization. Counterfeit medicines: Key facts. 2009. http://www.who.int/medicines/services/counterfeit/CfeitsFact SheetJuly09.pdf.
4. Pitts PJ. 21st Century International Drug Terrorism. Testimony by CMPI Director, Peter J. Pitts, to the Government Reform Committee Subcommittee on Criminal Justice, Drug Policy and Human Resources. 2005. http://special. pacificresearch.org/pub/ sab/health/2005/21-Century-Counterfeiting-Testimony. pdf.
5. Venhuis BJ, Barends DM, Zwaagstra ME, de Kaste D. Recent developments in counterfeits and imitations of Viagra, Cialis and Levitra: a 2005-2006 update. RIVM Report 370030001. 2007. http://www.rivm.nl/bibliotheek/rapporten/370030001. pdf.
6. Forzley M. Counterfeit goods and the public's health and safety. International Intellectual Property Institute (IIPI). 2003. http:// www.iipi.org/reports/Counterfeit-Goods.pdf.
7. Kao SL, Chan CL, Tan B, Lim CC, Dalan R, Gardner D, et al. An unusual outbreak of hypoglycemia. N Engl J Med. 2009; 360:734-6.
8. Sugita M. Risk analysis for health impairment due to the use of counterfeit drugs in Japan using phosphodiesterase type 5 inhibitor (PDE5I) as an example. Nohon Seikino Gakkai-zasshi (Jpn J Sex Med). 2008;23:299-309 (in Japanese with English abstract).
9. Pfizer Japan Inc. Adoption of technology of radio frequency identification (RFID) by Pfizer Japan Inc: for health of patients against counterfeit Viagra: technology against counterfeits sup¬pliers. 2006 (in Japanese).
10. Pfizer Japan Inc. Dangerous counterfeit Viagra. 2008 (in Japa¬nese) http://www.ed-info.net/health.html.
11. Ogasawara N. Forged medicines and its preventive measures. Nihon Hoso Gakkai-shi (J Packag Sci Technol Jpn). 2007; 16:367-75 (in Japanese).
12. Kimura K. Risk by counterfeit medicines which spread globally. Pfizer Forum. 2007;100 (in Japanese) http://www.pfizer.co.jp/ pfizer/healthcare/pfizer- forum/2007/n100.html.
13. Bayer Yakuhin Ltd. Information on an acceptance of an appli¬cation for prohibiting counterfeits of Levitra®, medicine for erectile dysfunction. 2006 (in Japanese) http://byl.bayer.co.jp/ scripts/pages/jp/press-release/ press-detail/file-path=2006%2 Fnews2006-12-18.html.
14. Eli Lilly Japan Ltd. Be careful about counterfeits of Cialis®: Additional information about an attention to ED care support on a website. 2008 (in Japanese) http://www.lilly.co.jp/CACHE/ news-2008-13.cfm.
15. Sankei Shimbun Co Ltd. Kamagra. Yukan Fuji. 28 Oct 2008 (in Japanese).
16. Yakuji Nippo Ltd. Viagra: Half of drugs imported privately are counterfeits. Yakuji Nippo. 1 Dec 2006 (in Japanese) http:// www.yakuji.co.jp/entry1744.html.
17. Mainichi Newspapers Co Ltd. Internet retailing of counterfeit Viagra. Mainichi Newspaper (Osaka version) morning edition, 20 Mar 2007. p. 23 (in Japanese).
18. Nagoya Customs, Japan. Situation of crackdown on violation of Customs Law at Nagoya Customs, Japan in 2008. 2009 (in Japanese) http://www.customs.go.jp/ nagoya/content/H20tekihatu- nagoya.pdf.
19. Cleaver T. Economics: the basics. London: Routledge; 2004.
20. Stiglitz JE, Walsh CE. Economics. 4th ed ed. New York: Norton; 2006.
21. Black J, Hashimzade N, Myles G A dictionary of economics. 3rd ed ed. Oxford: Oxford University Press; 2009.
22. Tsuchida S. Risk perception and risk communication: The Soci¬ety for Risk Analysis, Japan. Nihon Eisei Gakkai-zasshi (Jpn J Hyg). 2007;62:325-6 (in Japanese).
23. Arrow KJ. Uncertainty and the welfare economics of medical care. Am Econ Rev. 1963;58:941-73.
24. Akerlof G The market for lemons: quality uncertainty and the market mechanism. Q J Econ. 1970;84:488-500.
25. Shiozawa S. An introduction to economics. Tokyo, Yuhikaku. 1996 (in Japanese).
26. Goto R, Takahashi Y, Nishimura S, Ida T. A cohort study to examine whether time and risk preference is related to the success of smoking cessation? Addiction. 2009;104:1018-24.